Using heart ultrasound to find and treat heart failure risk in diabetes
Part of Heart & circulation, Hormones & metabolism clinical trials.
This trial tests a special software (Ultromics EchoGo) that looks at your heart ultrasound to find people with type 2 diabetes who are at high risk for heart failure. If you're at risk, the software helps your doctor decide on treatments to prevent heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have type 2 diabetes
- You have a high WATCH DM score (a measure of heart failure risk)
- You have had an echocardiogram (heart ultrasound) in the last 6 months
- You have never been diagnosed with heart failure
- You are able to take newer medications for diabetes and heart health (like GLP-1s, SGLT2 inhibitors, or certain MRA drugs)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial helps primary care providers screen and prevent heart failure in people with Type 2 diabetes. It uses a simple blood test to find early signs of heart problems.
This study uses heart ultrasound (echocardiography) to measure right-side heart function in people with type 2 diabetes, and to see how these findings relate to future health outcomes. It may help doctors better predict risk in diabetes by linking ultrasound results to prognosis.
This study tests whether messages from a large language model (a type of AI) can help doctors prescribe the right medicines for heart failure. It may help people with heart failure get the best guideline-recommended treatments.
This study looks for blood markers that may help explain or predict heart problems in people who have type 2 diabetes and heart failure. To join, you may also need to be having a planned heart procedure where doctors can collect study information.
This study looks at how cells talk to each other in people who have both diabetes and heart failure. It may help doctors understand these conditions better.
This trial tests if a smartphone app or similar remote tools can help doctors catch early signs that heart failure is getting worse in people who have a defibrillator (ICD) or biventricular pacemaker (CRT) that sends data to the clinic. Participating helps researchers figure out if this type of check-in from home works better than standard care.
Hear when a new Heart failure trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.